SCHEMBL18975191

SCHEMBL18975191

CCOP(=O)(O)CN(Cc1ccccc1)CC(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.41
▸ POLB P06746 4/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ ABCB1 P08183 1/20 0.37
▸ PRMT5 O14744 2/20 0.37
▸ WDR77 Q9BQA1 2/20 0.37
▸ BACE1 P56817 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22446608 0.92 ALDH1A1 (0.39) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL18975286 0.91 ALDH1A1 (0.41) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL5557205 0.83 ALDH1A1 (0.46) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL22562924 0.80 ALDH1A1 (0.37) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL18975189 0.80 ALDH1A1 (0.44) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL22446610 0.74 POLB (0.42) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL22446635 0.74 ADRA1B (0.36) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL18975269 0.73 BACE1 (0.45) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL5551381 0.73 ALDH1A1 (0.43) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL18975218 0.73 POLB (0.42) ALDH1A1POLBMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11021451-B2 Contrast agents BRACCO IMAGING S.P.A. (IT) 2021-06-01 — — US disclosed
EP-3386953-B1 CONTRAST AGENTS BRACCO IMAGING SPA (IT) 2020-10-21 — — EP disclosed
US-20200325108-A1 CONTRAST AGENTS BRACCO IMAGING S.P.A. (IT) 2020-10-15 — — US disclosed
US-10781188-B2 Contrast agents BRACCO IMAGING S.P.A. (IT) 2020-09-22 — — US disclosed
WO-2017098038-A1 CONTRAST AGENTS BRACCO IMAGING SPA (IT) 2017-06-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11021451-B2 Contrast agents SLC39A14, ABCB7, SLC40A1 ALDH1A1 4417/4885POLB 3285/4885MEN1 323/4885
US-20200325108-A1 CONTRAST AGENTS SLC39A14, ABCB7, SLC40A1 ALDH1A1 4417/4885POLB 3285/4885MEN1 323/4885
US-10781188-B2 Contrast agents SLC39A14, ABCB7, SLC40A1 ALDH1A1 4417/4885POLB 3285/4885MEN1 323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback